Lupin share price gains over 2% as Q1 profit jumps 52% YoY

Lupin’s share price is showing signs of strength, and the market's taking notice. The pharma stock jumped over 2 per cent today (August 7, 2025), reacting to a strong Q1 performance and growing optimism around global demand. But as the dust settles, here’s the real question: Is Lupin gearing up for a sustained run, or is this just a short-term sugar rush? Q1 FY26 results snapshot Here’s how the June quarter numbers stack up: Metric Q1 FY26 Q1 FY25 YoY change Revenue (Rs crore) 4,945  4,330  14.2 per cent EBITDA (Rs crore) 1,092  781  39.8 per cent EBITDA margin (%) 22.1 18 410 bps Net profit (Rs crore) 1,221  805  51.7 per cent